Comparison of the Immediate Effects of Physiotherapist and Self-administered Myofascial Release Techniques on Flexibility and Jumping Ability in Basketball Players

April 6, 2023 updated by: Yeditepe University
Basketball is an aerobic-based anaerobic sport that calls for both high-intensity movements like jumping (for rebounds, blocks, and shots), spins, dribbling, sprinting, and screening and low-intensity movements like walking, stopping, and running.This sport requires sudden and fast movements where jumping performance is often a decisive factor for sporting success and Whether crouching in a defensive situation or throwing a long pass, a player needs to have a sufficient level of flexibility for adequate efficiency. Fascia connects the structures of the body with muscles, nerves and blood vessels. Limitations may occur due to injury. These limitations can reduce flexibility, strength, endurance and coordination.Therefore, this study aims to compare the acute effects of manual and self-myofascial release on flexibility and jump performance in basketball players. The secondary aim was to examine the acute improvements in flexibility and jump performance after myofascial therapy.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Basketball is a sport that changes very fast and quickly on the court and involves being always ready and mobile to pass, shoot, dribble or rebound. Some performance-related physical fitness parameters of basketball are: speed, flexibility, endurance, body composition, strength, agility, coordination. Some performance-related physical fitness parameters of basketball are: speed, flexibility, endurance, body composition, strength, agility, coordination.As a result of the high thrust forces generated during jumping and the eccentric forces applied to the lower body during landing, these athletes place great stress on their ankles and knees and require a high degree of force application and the ability to safely control eccentric landing forces.These functional changes are mainly controlled by the lower limbs, but lower limb control is influenced by range of motion, which affects flexibility when strength is reduced." It is easy to see why flexibility is so important for effective basketball sport efficiency.Flexibility is important in both prevention and rehabilitation of musculoskeletal injuries. When looking at sports performance, the hamstring and gastrocnemius muscles have a fundamental role in the myofascial chain defined by Myers. Myofascial release is a series of manual therapy techniques that involve applying pressure to soft tissue (fascia) to achieve structural and mechanical adaptation.The therapist applies a continuous, slow and steady pressure on the restricted tissue barrier and when the tissue relaxes, a new tissue barrier is applied.While continuous pressure applied to fascia tissue is called direct treatment and traction applied is called indirect treatment, another treatment method is self-myofascial release. Self-Myofascial Release (SMR) is performed by applying pressure on restricted fascia tissue using various materials and one's own body weight in different body positions. The material used can be foam roller, vibrating foam roller.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
36

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Turkey
    • Maltepe
      • Istanbul, Maltepe, Turkey, 34776
        • Büşra
        • Contact:
        • Principal Investigator:
          • Elif Tuğçe Çil, Doctor
        • Sub-Investigator:
          • Hazal Yeşilkaya, Master
      • Istanbul, Maltepe, Turkey, 34770
      • Istanbul, Maltepe, Turkey, 34770

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 15 to 45 years of age,
  • gastrocnemius and hamstring muscle injuries. absence of pes planus and plantar heel pain

Exclusion Criteria:

  • presence of a disease in which manual application cannot be performed (tumour, fracture, rheumatoid arthritis, osteoporosis, severe vascular disease, etc.),
  • history of surgery in the lower extremity in the last 6 months,
  • diagnosis of fibromyalgia syndrome,
  • chronic pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Foam Roller group
Myofascial release with foam roller, hamstring and gastrocnemius muscle groups were trained with foam roller for 30 seconds with 2 repetitions
Other: Self myofascial Release
Myofascial release participants on their own will roll the foam roller in each area for two minutes.
Other Names:
  • SMFR
Active Comparator: Manual myofascial release group(Hands on)
We used the following treatment protocol for all patients in the MFR group. The techniques were performed by a physiotherapist with experience in MFR.
Other: myofascial release
Myofascial release will be applied to the participants by the physiotherapist.
Other Names:
  • Hands-on

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
counter movement jump(CMJ)
Time Frame: a day before the rehabilitation
Players were asked to jump as high as possible; the highest jump will then was recorded in centimeter scoring: The timing mat may give a score of the time in the air, and the calculated vertical jump height can be calculated. Height can be calculated using this formula: jump height = 4.9 x (0.5 x Time)^2 ). The jump height is usually greater than achieved with the Squat Jump.
a day before the rehabilitation
counter movement jump(CMJ)
Time Frame: at the time of discharge(2 weeks)
Players were asked to jump as high as possible; the highest jump will then was recorded in centimeter scoring: The timing mat may give a score of the time in the air, and the calculated vertical jump height can be calculated. Height can be calculated using this formula: jump height = 4.9 x (0.5 x Time)^2 ). The jump height is usually greater than achieved with the Squat Jump.
at the time of discharge(2 weeks)
Squat jump (SJ)
Time Frame: a day before the rehabilitation
The squat jump test measures explosive strength. This test is performed by starting with your knees bent in a 90 degree angle, and jumping vertically as high as possible from that position. Hands should be held on the hips to avoid the effect of arm swinging to the test.
a day before the rehabilitation
Squat jump (SJ)
Time Frame: at the time of discharge(2 weeks)
The squat jump test measures explosive strength. This test is performed by starting with your knees bent in a 90 degree angle, and jumping vertically as high as possible from that position. Hands should be held on the hips to avoid the effect of arm swinging to the test.
at the time of discharge(2 weeks)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
sit and reach test
Time Frame: a day before the rehabilitation
The sit and reach test will be used to assess lumbar and hamstring flexibility will be applied. The sit and reach test will be performed through the lumbopelvic region and hamstrings It is widely used to estimate flexibility. Sit with your feet in a V shape touching the tape, feet about a foot apart, with the measuring tape in between your legs, the 0 end starting where your legs part. Overlap your hands with arms outstretched in front of you. Practice three times, leaning forward and reaching your hands out.
a day before the rehabilitation
sit and reach test
Time Frame: at the time of discharge(2 weeks)
The sit and reach test will be used to assess lumbar and hamstring flexibility will be applied. The sit and reach test will be performed through the lumbopelvic region and hamstrings It is widely used to estimate flexibility. Sit with your feet in a V shape touching the tape, feet about a foot apart, with the measuring tape in between your legs, the 0 end starting where your legs part. Overlap your hands with arms outstretched in front of you. Practice three times, leaning forward and reaching your hands out.
at the time of discharge(2 weeks)
knee - wall tests
Time Frame: a day before the rehabilitation
The test requires a wall and a measuring tape. The measuring tape is attached to the wall touching and placed on the floor perpendicular to the wall. Tape the participant's foot is asked to step on it. The heel and 2nd toe are asked to be on the line. The participant then tries to touch the knee to the vertical line drawn on the wall ahead. The participant can use support while moving forwards. The participant should place his/her foot on the line. takes the knee as far as it can go without lifting it. In the last case, the test at the moment when the knee of the leg touches the wall and the heel of the foot on the tape touches the floor the measurement will take place at the point where it will be pressed. To understand the test and to ensure that the correct measurement.3 measurements will be made in order to be taken. The big toe of the foot tested with the wall distance (cm) will be noted. The best of three trials for data analysis will be taken into account.
a day before the rehabilitation
knee - wall tests
Time Frame: at the time of discharge(2 weeks)
The test requires a wall and a measuring tape. The measuring tape is attached to the wall touching and placed on the floor perpendicular to the wall. Tape the participant's foot is asked to step on it. The heel and 2nd toe are asked to be on the line. The participant then tries to touch the knee to the vertical line drawn on the wall ahead. The participant can use support while moving forwards. The participant should place his/her foot on the line. takes the knee as far as it can go without lifting it. In the last case, the test at the moment when the knee of the leg touches the wall and the heel of the foot on the tape touches the floor the measurement will take place at the point where it will be pressed. To understand the test and to ensure that the correct measurement.3 measurements will be made in order to be taken. The big toe of the foot tested with the wall distance (cm) will be noted. The best of three trials for data analysis will be taken into account.
at the time of discharge(2 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Yeditepe University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Elif Tuğçe Çil, doctor, Yeditepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 8, 2023

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
April 15, 2023

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 4, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 16, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 6, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 11, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 11, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 6, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • YEDITEPEU-BUSRAKOCAKILIC-00096

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings